<DOC>
	<DOCNO>NCT02356627</DOCNO>
	<brief_summary>The purpose study examine effectiveness cost-effectiveness Cancer Home Life Intervention compare usual care performance participation everyday activity quality life people advance cancer living home .</brief_summary>
	<brief_title>The Cancer Home Life Intervention Study . A Randomised , Controlled Multicentre Trial Health Economic Evaluation</brief_title>
	<detailed_description>The sample size base primary outcome measure : mean Activty Daily Living ( ADL ) motor ability 1.04 logits ( SD 0.727 ) measure Assessment Motor Process Skills ( AMPS ) . A significance level 0.05 would provide 80 % power detect between-group difference 0.3 logits require sample size N=184 . An expected drop-out rate 32 % 3 month follow-up mean 272 patient advanced cancer must include study three hospital . Multiple imputation use estimate plausible value miss data participant lose follow-up due reason death . This , however , apply primary outcome data estimation compute . For normally distribute ratio data intervention group compare control group use multiple linear regression analysis mean change baseline . Logistic regression analysis use ordinal data . Adjustments hospital baseline value make . A modified intention-to-treat analysis apply . Subgroup analyse identifiy group especially benefit intervetnion perform . The cost-effectiveness analysis wil perform ADL motor ability clinical parameter , cost-utility analysis base calculation Quality Adjusted Life Years ( QALY ) . The Incremental Cost-effectiveness Ratio ( ICER ) calculate result summarise cost-effectiveness acceptability curve ( CEAC ) .</detailed_description>
	<criteria>â‰¥18 year old Diagnosed cancer Evaluated incurable responsible oncologist respective outpatient unit Functional level 12 WHO performance scale Live within radius maximum 60 km AUH NH island Funen Live private home shelter living Know sufficient Danish fill questionnaires participate interview . Cognitive impairment prevent participant participate structure interview Live nursing home hospice Considered incapable comply trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Occupational therapy</keyword>
	<keyword>Adaptive intervention</keyword>
	<keyword>Home-based</keyword>
	<keyword>Assistive Technology</keyword>
	<keyword>Home modification</keyword>
	<keyword>Clinical effectiveness</keyword>
	<keyword>Cost-effectiveness</keyword>
	<keyword>Cost-utility</keyword>
</DOC>